We recently showed that T. cruzi parasites enhance expression of co-stimulatory surface molecules on cord blood myeloid dendritic cells (mDCs). This study aims to gain insight into the role of live parasites and intracellular infection in mDC activation using CSFE-labelled parasites. First, we observed that only a low proportion of mDCs was infected by T. cruzi after overnight culture of whole blood samples and trypomastigotes, as compared with monocytes and granulocytes. Cord blood mDCs were also less infected than their adult counterpart. Second, expression levels of HLA-DR and co-stimulatory molecules CD80, CD83 and CD86 were similar on infected and uninfected mDCs. Parasite lysate also triggered mDCs phenotypic maturation of both cord and adult blood cells, though in a lower extent than live parasites. These results strongly support a central role for extracellular trypomastigotes in activation of mDCs when parasites are incubated with whole blood cells. However, viability of trypomastigotes was not absolutely required for mDC activation.
Introduction
Trypanosoma cruzi is the parasitic protozoan agent of Chagas' disease, a major cause of morbidity and mortality in Latin America, currently infecting 8-10 million persons [33] . One to 12% of T. cruzi-infected pregnant women transmit the parasite to their foetuses [7, 8] . In previous studies, we showed that: (i) uninfected newborns from T. cruzi-infected mothers display a potent inXammatory environment [50] , (ii) newborns congenitally infected with T. cruzi develop an adult-like parasite-speciWc CD8 + T cell response producing interferon(IFN)- [16] and (iii) 6-to 7-month-old infants born to T. cruzi-infected mothers displayed boosted type 1 immune responses to Bacillus Calmette Guerin (BCG), hepatitis B virus (HBV), diphtheria and tetanus vaccines after routine immunization [11] . These data point out a T. cruzi-associated immunological imprinting of immune responses in early life by maternal and/or congenital infection, overcoming immunological immaturity in early life and resulting in parasite-speciWc as well as boosted heterologous responses, such as those mounted to vaccine antigens. The mechanisms underlying such immunological imprinting on neonatal immune responses remain unclear.
In a recent work, we also reported that live T. cruzi parasites enhance expression of co-stimulatory surface molecules on cord blood myeloid dendritic cells (mDCs) and that T. cruzi-activated mononuclear cells from cord blood, containing activated mDCs, promote proliferation of CD8 + T cells and type 1-polarized response [34] , whereas other studies showed that T. cruzi inhibits the response to lipopolysaccharide (LPS) of monocyte-derived DCs (MoDCs) from adult blood [48, 49] . The present work aims to determine the susceptibility of mDCs and other leucocytes to T. cruzi infection and to decipher the role of extracellular versus intracellular, as well as live versus lysed parasites, in activation of cord blood mDCs. The response of cord blood cells is in addition compared with that of adult cells.
Materials and methods

Blood samples
Umbilical cord blood samples were collected from healthy newborns at the maternity ward of the Erasme Hospital (Brussels, Belgium) after obtaining informed consent from their mothers. Blood samples of healthy adults were obtained from volunteer donors. Blood collection was performed in agreement with the ULB ethical committee guidelines. All blood samples were collected in endotoxinfree heparinized tubes (Becton-Dickinson) and processed within 6 h of collection.
Preparation of CSFE-labelled T. cruzi parasites
Trypanosoma cruzi trypomastigotes [TcVI genotype, Tulahuen strain] [56] were obtained from the supernatant of cultured infected Wbroblasts as described previously [14] . Parasites were veriWed to be Mycoplasma-free by PCR (VenorGeM-Mycoplasma detection Kit, Lucron Bioproducts, Sint Martens-Latem, Belgium). In some experiments, parasite lysate, obtained after 8 successive cycles of freezing-thawing as previously described [50] , was used instead of live parasites.
Live trypomastigotes were labelled with carboxyXuorescein succinimidyl ester (CFSE, Invitrogen, Merelbeke, Belgium) as described elsewhere [39] , with slight modiWcations. BrieXy, 0.5 £ 10 6 parasites/mL were suspended in DMEM (Dulbecco's ModiWed Eagle Medium, Lonza) containing 2.5 M CFSE and incubated 10 min at 37°C under 5% CO 2 atmosphere. Parasites were then washed twice with DMEM by centrifugation at 4,000 g and resuspended in RPMI 1640 before use. CSFE labelling did not alter the viability of trypomastigotes as assessed by their mobility under light microscope.
Whole blood cell incubation with T. cruzi parasites Whole blood cells were cultured with T. cruzi parasites as previously described [34] . BrieXy, 2 mL of whole blood samples half-diluted in RPMI 1640 medium containing 2 mM L-glutamine, 25 mM HEPES, penicillin 100 U/mL and streptomycin 100 g/mL (Lonza, Verviers, Belgium) was incubated with 10 6 or 10 7 CSFE-labelled live parasites/ mL (i.e. roughly 15-30 parasites per 100 leucocytes using 10 6 T. cruzi/mL) or medium only for 16 h at 37°C in a humidiWed atmosphere containing 5% CO 2 . In some experiments, unlabelled live parasites or parasite lysate were used instead of live parasites at the same amounts as described above.
Determination of intracellular infection level
After whole blood incubation as described above, the percentage of T. cruzi-infected cells were determined either by microscopic examination of Giemsa-stained cells spun on microscope slides using a cytofuge, or by Xow cytometry analyses (considering the ratio between the numbers of CSFE + cells and total cells in the same gate, see below). Mean Xuorescence intensity (MFI) of CSFE + cells was used as a relative marker of amastigote amount per cell.
Flow cytometry analysis of leucocytes
After incubation with parasites, blood samples were centrifuged at 450 g for 5 min at room temperature (RT), and half of the medium was discarded. The pellet was re-suspended in the remaining supernatant. Two hundred L of cell suspension was distributed into polystyrene round tubes and incubated with Xuorochrome-labelled antibodies together with FcR blockage reagent (Miltenyi Biotec, Bergisch Gladbach, Germany) for 20 min at RT in the dark. Erythrocytes were then lysed by adding 2 mL of FACS Lysing solution (BD Biosciences, Erembodegem, Belgium) for 10 min at RT. After two washings with FACS Wash BuVer (BD Biosciences), cells were re-suspended in FACS Fix solution (BD Biosciences). Data were acquired in a fourcolour Xow cytometry FACS Calibur cytometer and analysed using the Cell Quest software (Becton-Dickinson version 6.0).
The following monoclonal antibodies and their matched isotype controls were used: lineage cocktail 1-FITC ("Lin1", containing Ab against CD3, CD14, CD16, CD19, CD20 and CD56), anti-CD34-FITC (clone 581), anti-CD11c-APC (clone B-ly6), anti-HLA-DR-PerCP (clone L243), anti-CD40-PE (clone 5C3), anti-CD80-PE (clone L307.4), anti-CD83-PE (clone HB15e), anti-CD86-PE (clone 2331 FUN-1), anti-CD19-PerCP (clone SJ25C1), anti-CD19-PE (clone 4G7), anti-CD14-PerCP (clone MoP9), anti-CD56-APC (clone N901 NKH1), anti-CD3-PerCp (clone SK7) (all supplied by BD Biosciences), and anti-CD1c-APC (clone AD5-8E7 1 obtained from Miltenyi). The following combinations of antibodies were used : (1) CD1c-APC, CD19-PerCP, CD80-PE, CD83-PE or CD86-PE, along with CSFE-labelled parasites for evaluating expression of surface markers in association with infection; (2) Lin1-FITC (with CD34-FITC for cells of cord blood), HLA-DR-PerCP, CD11c-APC and CD40, CD80, CD83, or CD86-PE for studying co-stimulatory molecules on myeloid DCs (mDCs); (3) CD14-PerCP or CD3-PerCP in combination with CD19-PE and CD56-APC along with CSFE-labelled parasites for evaluating the level of infection of monocytes, B, T lymphocytes and NK cells.
Analyses were performed as previously described [34] . The expression levels of co-stimulatory molecules on mDCs incubated with unlabelled or CSFE-labelled trypomastigotes were similar and as described previously [34] , indicating that CSFE did not interfere with the process of activation or with analyses performed by Xow cytometry (data not shown).
Expression of results and statistical analysis
Results are expressed as arithmetic means ( §SEM) or Box and Whisker plots (showing medians, quartiles and 5-95th percentiles). Statistical comparisons were performed with Student's t test or Mann-Whitney Wilcoxon U-test (paired or not, depending on the analysed data). Statistical analyses were conducted using GraphPad Prism software 5.02 (GraphPad Software Inc., San Diego, CA).
Results
Validation of CSFE-labelled T. cruzi as a tool for determining leucocyte infection
As shown in Fig. 1a , Xow cytometry indicated CSFE procedure suitable for obtaining homogenous and highly intense labelling of trypomastigotes, rendering them easily identiWable. Examination by Xuorescence microscopy of leucocytes incubated with CSFE-labelled parasites clearly identiWed intracellular spherical T. cruzi amastigotes, whereas some cells displayed Xuorescent elements suggestive of amastigotes at diVerent levels of degradation (Fig. 1b) . To validate the use of CSFE-labelled parasites for measuring amounts of infected cells, we compared the proportions of CSFE + leucocytes determined by Xow cytometry and of amastigote-infected cells determined by microscopic observation of Giemsa-stained slides, at diVerent parasite to cell ratios. Figure 1c shows the signiWcant correlation observed between both proportions, with a slope close to 1 (r = 0.951, p < 0.0001), indicating that most infected cells were detectable using CSFE-labelled parasites, and, conversely, that cells having eventually phagocytised or adsorbed at their surface CSFE + debris without being infected were not detected in our conditions. + ) cells remained all CSFE negative. Figure 2 compares infection rates of granulocytes, monocytes and mDCs in cord and adult blood. Three main observations have to be underlined. First, the proportion of neonatal mDCs susceptible to T. cruzi infection was signiWcantly lower than monocytes (by roughly fourfold) and granulocytes (by 2.4 fold with 10 7 parasites/mL) ( Fig. 2a ). Similar diVerences in the susceptibility to T. cruzi infection were observed between adult mDCs, monocytes and granulocytes (Fig. 2b) . Second, by contrast with monocytes and granulocytes, mDCs from cord or adult blood appear to allow the entry of a limited number of parasites since the amount of intracellular amastigotes (MFI) did not increase when raising the parasite amounts incubated with blood cells (Fig. 2c, d ). Third, cord and adult mDCs present diVerent susceptibilities to T. cruzi infection. Indeed, infections rates of mDCs were signiWcantly lower by half in cord than in adult blood at both used parasite concentrations (Fig. 2a, b) . Meanwhile, infected cord mDCs displayed two-fold higher MFI, suggesting that they contained more amastigotes than adult mDCs (Fig. 2c, d ).
Determination of T. cruzi
Expression of co-stimulatory surface molecules on T. cruziinfected and -uninfected cord blood myeloid dendritic cells Based on our previous work [34] , we thus investigated the role of intracellular parasites in mDC activation by incubating blood cells with CSFE-labelled trypomastigotes in order to analyse expression of co-stimulatory molecules on infected (CSFE + ) and uninfected (CSFE ¡ ) cells. As shown in Table 1 , the proportions of cells positive for CD80, CD83 and CD86, as well as their MFI expression levels, were comparable in infected and uninfected cord blood mDCs, whatever the incubating parasite load. Figure 3a illustrates CD80 and CD83 expression in one representative experiment, underlining the T. cruzi-associated mDCs activation previously reported [34] . In addition, the simultaneous presence of infected activated (CSFE + CD83 + ), unactivated infected (CSFE + CD83 ¡ ) and activated uninfected (CSFE ¡ CD83 + ) cells suggests that intracellular infection was not essential for mDC activation. Analogous observations were made with adult mDCs (Table 1 and Fig. 3b ). These results strongly support a central role for extracellular trypomastigotes in activation of mDCs.
Expression of co-stimulatory surface molecules on cord blood myeloid dendritic cells incubated with lysed or live T. cruzi parasites
We also compared the eVect of live and lysed trypomastigotes (used at the same amount of 10 7 parasites/mL) on expression of HLA-DR and co-stimulatory molecules on mDCs. Figure 4a shows that T. cruzi lysate up-regulated the expression of HLA-DR, CD40 and CD80 on cord blood mDCs to nearly similar proportions and/or MFI of positive cells than those observed with live parasites. Expression levels (MFI) of CD40 and CD80 were enhanced by three to fourfold in the presence of lysate or live parasites as compared to controls without parasites. The lysate also induced CD83 expression on mDCs from cord blood, though its activating eVect was signiWcantly lower than live parasites. Comparable observations were made with adult mDCs, though lysed parasites displayed a less-pronounced eVect than live parasites on CD80 (Fig. 4b) . These results show that viability of trypomastigotes is not required to induce mDC activation.
Discussion
Altogether, our results show that (1) T. cruzi infects a relatively low proportion of cord blood mDCs as compared to monocytes and granulocytes, (2) live and, in a less extent, lysed T. cruzi parasites are able to induce the expression of co-stimulatory molecules on cord blood mDCs and (3) mDCs intracellular infection does not enhance this eVect. Trypanosoma cruzi can invade a large panel of cell types [3, 37, 55] . However, few studies have compared the susceptibility of human leucocytes sub-populations to infection with T. cruzi trypomastigotes [39] . Our results highlight high infection rates of monocytes and granulocytes and the low ones observed for mDCs from cord and adult blood, despite a much higher relative parasite to cell ratio than for other blood cell types since mDCs are much less numerous in blood [43] . Our observation that blood mDCs are infected with T. cruzi conWrms a previous report showing human monocyte-derived DCs (MoDCs) to be permissive to T. cruzi infection and support intracellular multiplication [49] . The proportion of infected DCs we observed were in the same range than those previously reported after in vitro infection of mouse bone marrowderived CD11c + cells [30] . The higher T. cruzi infection rate of monocytes and granulocytes might rely on their greater capacity of phagocytosis as compared with mature DCs [41] . On the other hand, cord blood MoDCs have been shown to display reduced endocytic capacity than adult MoDCs. This feature might contribute to explain the higher T. cruzi infection rate of adult versus cord blood mDCs. However, the reasons why infected cord mDCs harbour higher intracellular amastigote amounts (MFI estimation) than adult mDCs remain unknown. Our data also show that, in our experimental conditions, T and B lymphocytes as well as NK cells were not infected with T. cruzi, in agreement with their very low permissivity to T. cruzi invasion [39, 51] .
The fact that T. cruzi can infect large proportions of leucocytes in cord blood is of interest for the parasitological diagnosis of congenital infection. Indeed, such diagnosis at birth is mainly based on the detection of motile T. cruzi trypomastigotes by microscopic examination of fresh cord blood. Targeting microscopic investigations on detection of intra-leucocyte amastigotes, in addition to standard investigations of extracellular free trypomastigotes, might increase the sensitivity of such parasitological diagnosis. Moreover, infection of leucocytes might contribute to explain the higher sensitivity of PCR over standard parasitological diagnosis, by detecting DNA from both trypomastigote and amastigote forms of T. cruzi parasite [8, 42] .
Our observations that (1) a relatively low proportion of mDCs is infected when encountering T. cruzi trypomastigotes, (2) infected as well as uninfected mDCs incubated with parasites express activation markers at similar levels and (3) lysed (i.e. in absence of cell infection) as well as live trypomastigotes activate mDCs, strongly suggest that extracellular trypomastigotes and not intracellular parasites mainly contribute to mDC maturation. These results are in line with our previous observation in mouse infected with the other intracellular trypanosomatidae Leishmania, showing DC activation to depend on recognition of live parasites but not on parasite internalization [13] . DCs can be activated through the engagement of surface receptors by microbial molecules or by exposure to inXammatory signals generated following exposure to a pathogen [40] . Some molecules shed by T. cruzi have been described to directly activate murine DCs or human MoDCs. The parasite protease cruzipain, by acting on kininogen (a plasmatic protein present in our whole blood cultures), produces bradykinin that triggers Ca 2+ mobilization in DCs and their activation [35] . Tc52, a shed trypanothione-glutathione thioltransferase, activates DCs through TLR2 [27] . In addition, TLR2 engagement by released glyco-phosphatidylinositol anchors from the parasite surface might help maturating them [6, 21] . However, as previously mentioned [34] , TLR4 (recognizing surface molecules of T. cruzi or activated by parasite trans-sialidases independently of PAMP recognition [2, 26] ) and TLR9 (recognizing T. cruzi DNA sequences [4] ) are probably not involved in activation of such cells. Indeed, the proWle of cytokines released in response to T. cruzi-activated mDCs does not support TLR4 engagement [34] . Moreover, the absence of the endosomal TLR9 expression by mDCs, known to recognize T. cruzi DNA sequences and to potently activate DCs, might contribute to explain the absence of activating eVect of intracellular parasites [4, 21, 52] . The possible role of these shed molecules (cruzipain, Tc52, gpi anchors) in mDC activation is, however, in contrast with the observation of Van Overtvelt et al. showing that T. cruzi released molecules did not induce expression of co-stimulatory molecules on human MoDCs [49] . This discrepancy may arise from the fact that shedding of some molecules might require contact between parasites and host cells and be absent in preparations of spontaneously released molecules obtained in vitro by incubating parasites without other cells, like that used by Van Overtvelt. In accordance, we did not Wnd cruzipain and Tc52 in the secretome of T. cruzi trypomastigotes that we recently analysed (unpublished [3, 12, 37, 55] . Since T. cruzi trypomastigotes were co-cultured with whole blood cells, an additional bystander eVect of the numerous other infected cells such as monocytes and granulocytes also present in cord blood might account for the more potent activating eVect of live parasites on mDCs [17] . Such cells may indeed deliver additional inXammatory signals triggered by the parasite [19, 44, 45] . IFN--producing NK cells might also be involved. Indeed, others of our recent data indicate that T. cruzi is able to rapidly up-regulate the production of this cytokine by adult as well as cord blood NK cells ( [15] and manuscript in preparation).
Contradicting results about the ability of T. cruzi to properly activate DCs have been obtained by diVerent authors. Our present and previous results [34] are in line with others showing that live parasites or selected parasitederived molecules are able to induce functional maturation of human and murine DCs, endowing them to favour a protective type 1 T cell response ( [9, 10, 18, 24, 27, 28] and reviewed in [47] ). However, another study indicates that the parasite does not up-regulate MHC class II and co-stimulatory molecules on DCs, which in turn do not trigger T cell activation [30] . Such discrepancy likely relies on the environment in which DCs encounter parasites. Indeed, the genetic background of the host as well as the parasite strain has been shown to modulate the magnitude and the quality of DC maturation [1, 29] . Poncini et al. [30] have used a highly virulent parasite strain previously shown to impair DCs activation during acute T. cruzi infection [1] . Additionally, the use of puriWed DCs would impede the action of potential bystander signals delivered by other cells. However, some authors showing DC activation by T. cruzi have used puriWed populations of DCs, either monocyte-or bone marrow-derived [10, 18, 27, 28] , suggesting that a bystander stimulation is not absolutely required. Another element that is worth considering is that most studies showing DC-activating properties of T. cruzi are short-term studies performed either in vitro (24-48 h, [10, 18, 27, 28] ) or in vivo (Wrst days after the beginning of infection [9, 24] , while in chronic phase of the infection, DCs may present a deviated maturation proWle, producing more IL-10 and less IL-12 [10] . Since such proWle is akin to what is observed when the TLR4-ligand LPS is present during DCs-parasite (or parasite-derived molecules) co-cultures [5, 30, 31] , we may wonder whether co-infections with pathogens bearing TLR4-ligands, which may incidentally occur in some chronically infected patients, or leakage of such ligands from the intestinal Xora, which takes place in some pathologies [25] , might contribute to modulate the course of T. cruzi infection by curbing DC ability to maintain a protective immune response.
Extension of T. cruzi-associated mDCs activation to parasite-derived soluble molecule(s) is relevant in the maternal-foetal context. This means that all newborns of T. cruzi-infected mothers, including those uninfected at birth and having received parasite-derived circulating molecules transferred from their mothers (88 to 99% of them), as well as those congenitally infected with live parasites (1-12% of them), might harbour activated mDCs [7, 8] . This is in line with our previous observations showing that uninfected neonates from T. cruzi-infected mothers displayed a potent pro-inXammatory (pro-Th1) environment [50] .
Though mDC infection does not result in mDC overactivation, such infected cells might play a role in initiating MHC class I-dependent parasite-speciWc T cell responses, involving CD8 + T cells both cytotoxic and producing IFN-, in accordance with our observation in newborns congenitally infected with T. cruzi or with other infectious agents [16, 22, 46] . In addition, the large sub-population of parasite-uninfected mDCs activated during incubation with T. cruzi could process and present extracellular parasite antigens, as well as a large variety of T. cruzi-unrelated antigens for which immune responses would be boosted. This is supported by our previous report showing that 6-to 7-month-old infants born to T. cruzi-infected mothers display improved type 1 immune responses to BCG, HBV, diphtheria and tetanus vaccines after standard immunization [11] .
Our present results, added to our previous data showing that T. cruzi-activated mononuclear cells from cord blood, containing activated mDCs, promote proliferation of T cells and type 1-polarized response [34] , should encourage further studies aiming to identify and characterize parasitederived molecule(s) activating cord blood mDCs. Indeed, the initial polarization of the foetal/neonatal immune system towards a Th2 environment [20, 53] , the limited development of CD4+ Th1 cell responses essential for the control of intracellular pathogens [23, 36, 54] and of the production of antibodies [38] , favours the logistics of vaccine administration later in childhood rather than during the neonatal period in spite of infectious diseases being a leading worldwide cause of morbidity and mortality in early life [32] . So, the identiWcation of parasite-derived molecule(s) contributing to overcome the foetal/neonatal immunological immaturity, as well as the exploration of mechanisms underlying immunological imprinting in early life, would be of great interest for improving neonatal vaccinations. 
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